Dissecting mechanisms of resistance to targeted drug combination therapy in human colorectal cancer
Paul A. Clarke(Institute of Cancer Research), Paul Workman(Institute of Cancer Research)
Cited by 42
Related Papers
Guidelines for the welfare and use of animals in cancer research
|British Journal of Cancer|2010|1.4k
Discovery of small molecule cancer drugs: Successes, challenges and opportunities
|Molecular Oncology|2012|581
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations
|British Journal of Cancer|2005|513
New approaches to molecular cancer therapeutics
|Nature Chemical Biology|2006|387